Dimeric Prodrug Self-Delivery Nanoparticles with Enhanced Drug Loading and Bioreduction Responsiveness for Targeted Cancer Therapy.

Efficient drug accumulation in tumor cells is essential for cancer therapy. Herein, we developed dimeric prodrug self-delivery nanoparticles (NPs) with enhanced drug loading and bioreduction responsiveness for triple negative breast cancer (TNBC) therapy. Specially designed camptothecin dimeric prodrug (CPTD) containing a disulfide bond was constructed to realize intracellular redox potential controlled drug release. Direct conjugation of hydrophobic CPTD to poly(ethylene glycol) PEG5000, a prodrug-based amphiphilic CPTD-PEG5000 co-polymer was synthesized, which could encapsulate parental CPTD prodrug spontaneously and form ultrastable NPs due to the highly analogous structure. Such dimeric prodrug self-delivery nanoparticles showed ultrahigh stability with critical micelle concentration as low as 0.75 μg/mL and remained intact during endocytosis. In addition, neurotensin (NT), a 13 amino acid ligand, was further modified on the nanoparticles for triple negative breast cancer (TNBC) targeting. Optimized NT-CPTD NPs showed improved pharmacokinetics profile and increased drug accumulation in TNBC lesions than free CPT, which largely reduced the systemic toxicity and presented an improved anticancer efficacy in vivo. In summary, with advantages of extremely high drug loading capacity, tumor microenvironmental redox responsiveness, and targeted TNBC accumulation, NT-CPTD NPs showed their potential for effective triple negative breast cancer therapy.

[1]  C. Li,et al.  Enhanced bioreduction-responsive diselenide-based dimeric prodrug nanoparticles for triple negative breast cancer therapy , 2018, Theranostics.

[2]  Xiaoyuan Chen,et al.  Polymeric Nanoparticles with a Glutathione-Sensitive Heterodimeric Multifunctional Prodrug for In Vivo Drug Monitoring and Synergistic Cancer Therapy. , 2018, Angewandte Chemie.

[3]  Robert J. Ono,et al.  Dual pH-Responsive Shell-Cleavable Polycarbonate Micellar Nanoparticles for in Vivo Anticancer Drug Delivery. , 2018, ACS applied materials & interfaces.

[4]  Chen Jiang,et al.  Sequentially Triggered Nanoparticles with Tumor Penetration and Intelligent Drug Release for Pancreatic Cancer Therapy , 2018, Advanced science.

[5]  M. Mandal,et al.  Redox-Responsive Core-Cross-Linked Block Copolymer Micelles for Overcoming Multidrug Resistance in Cancer Cells. , 2018, ACS applied materials & interfaces.

[6]  Min Lin,et al.  Theranostics of Triple-Negative Breast Cancer Based on Conjugated Polymer Nanoparticles. , 2018, ACS applied materials & interfaces.

[7]  Lin Zhu,et al.  Building Stable MMP2-Responsive Multifunctional Polymeric Micelles by an All-in-One Polymer-Lipid Conjugate for Tumor-Targeted Intracellular Drug Delivery. , 2017, ACS applied materials & interfaces.

[8]  Xiaoyuan Chen,et al.  Transformative Nanomedicine of an Amphiphilic Camptothecin Prodrug for Long Circulation and High Tumor Uptake in Cancer Therapy. , 2017, ACS nano.

[9]  Chen Jiang,et al.  ROS-Switchable Polymeric Nanoplatform with Stimuli-Responsive Release for Active Targeted Drug Delivery to Breast Cancer. , 2017, ACS applied materials & interfaces.

[10]  Chen Jiang,et al.  Biomimetic Human Serum Albumin Nanoparticle for Efficiently Targeting Therapy to Metastatic Breast Cancers. , 2017, ACS applied materials & interfaces.

[11]  Qiang Sun,et al.  Photosensitizer enhanced disassembly of amphiphilic micelle for ROS-response targeted tumor therapy in vivo. , 2016, Biomaterials.

[12]  L. Dobrucki,et al.  Pamidronate functionalized nanoconjugates for targeted therapy of focal skeletal malignant osteolysis , 2016, Proceedings of the National Academy of Sciences.

[13]  C. Chiu,et al.  Distinct CPT-induced deaths in lung cancer cells caused by clathrin-mediated internalization of CP micelles. , 2016, Nanoscale.

[14]  Peijun Zhang,et al.  The self-assembling camptothecin-tocopherol prodrug: An effective approach for formulating camptothecin. , 2015, Biomaterials.

[15]  Jonathan Yen,et al.  Redox-Responsive Self-Assembled Chain-Shattering Polymeric Therapeutics. , 2015, Biomaterials science.

[16]  Wim E Hennink,et al.  Complete Regression of Xenograft Tumors upon Targeted Delivery of Paclitaxel via Π-Π Stacking Stabilized Polymeric Micelles. , 2015, ACS nano.

[17]  N. Zaffaroni,et al.  PLK1 is a critical determinant of tumor cell sensitivity to CPT11 and its inhibition enhances the drug antitumor efficacy in squamous cell carcinoma models sensitive and resistant to camptothecins , 2015, Oncotarget.

[18]  F. Uckun,et al.  Dimeric drug polymeric nanoparticles with exceptionally high drug loading and quantitative loading efficiency. , 2015, Journal of the American Chemical Society.

[19]  T. Ono,et al.  Augmented EPR effect by photo-triggered tumor vascular treatment improved therapeutic efficacy of liposomal paclitaxel in mice bearing tumors with low permeable vasculature. , 2015, Journal of controlled release : official journal of the Controlled Release Society.

[20]  Chen Jiang,et al.  Linear-dendritic copolymer composed of polyethylene glycol and all-trans-retinoic acid as drug delivery platform for paclitaxel against breast cancer. , 2015, Bioconjugate chemistry.

[21]  Andrew L. Ferguson,et al.  Investigating the optimal size of anticancer nanomedicine , 2014, Proceedings of the National Academy of Sciences.

[22]  Chen Jiang,et al.  A bacteria deriving peptide modified dendrigraft poly-l-lysines (DGL) self-assembling nanoplatform for targeted gene delivery. , 2014, Molecular pharmaceutics.

[23]  P. Forgez,et al.  Suicide HSVtk Gene Delivery by Neurotensin-Polyplex Nanoparticles via the Bloodstream and GCV Treatment Specifically Inhibit the Growth of Human MDA-MB-231 Triple Negative Breast Cancer Tumors Xenografted in Athymic Mice , 2014, PloS one.

[24]  S. Ren,et al.  Smart nanodevice combined tumor-specific vector with cellular microenvironment-triggered property for highly effective antiglioma therapy. , 2014, ACS nano.

[25]  F. Kiessling,et al.  Multidrug resistance: Physiological principles and nanomedical solutions. , 2013, Advanced drug delivery reviews.

[26]  Kinam Park,et al.  FRET imaging reveals different cellular entry routes of self-assembled and disulfide bonded polymeric micelles. , 2013, Molecular pharmaceutics.

[27]  J. Trédaniel,et al.  Neurotensin and its high affinity receptor 1 as a potential pharmacological target in cancer therapy , 2013, Front. Endocrin..

[28]  Jean-Pierre Gillet,et al.  Mechanisms of multidrug resistance in cancer. , 2010, Methods in molecular biology.

[29]  Kinam Park,et al.  Release of hydrophobic molecules from polymer micelles into cell membranes revealed by Förster resonance energy transfer imaging , 2008, Proceedings of the National Academy of Sciences.

[30]  Ernst Wagner,et al.  Programmed drug delivery: nanosystems for tumor targeting , 2007, Expert opinion on biological therapy.

[31]  Jianjun Cheng,et al.  Pharmacokinetics and biodistribution of the camptothecin–polymer conjugate IT-101 in rats and tumor-bearing mice , 2006, Cancer Chemotherapy and Pharmacology.

[32]  P. Forgez,et al.  Neurotensin counteracts apoptosis in breast cancer cells. , 2002, Biochemical and biophysical research communications.

[33]  M. Gottesman,et al.  Multidrug resistance in cancer: role of ATP–dependent transporters , 2002, Nature Reviews Cancer.

[34]  P. Cresswell,et al.  Enzymatic reduction of disulfide bonds in lysosomes: characterization of a gamma-interferon-inducible lysosomal thiol reductase (GILT). , 2000, Proceedings of the National Academy of Sciences of the United States of America.

[35]  R. Hertzberg,et al.  Camptothecin induces protein-linked DNA breaks via mammalian DNA topoisomerase I. , 1985, The Journal of biological chemistry.